Related references
Note: Only part of the references are listed.Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cut-points-a joint consensus statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine
Borge G. Nordestgaard et al.
EUROPEAN HEART JOURNAL (2016)
2016 European Guidelines on cardiovascular disease prevention in clinical practice
Massimo F. Piepoli et al.
EUROPEAN HEART JOURNAL (2016)
Postprandial hyperlipidemia as a potential residual risk factor
Kazufumi Nakamura et al.
JOURNAL OF CARDIOLOGY (2016)
Identifying an Optimal Cutpoint for the Diagnosis of Hypertriglyceridemia in the Nonfasting State
Khendi T. White et al.
CLINICAL CHEMISTRY (2015)
Genome-wide association study of triglyceride response to a high-fat meal among participants of the NHLBI Genetics of Lipid Lowering Drugs and Diet Network (GOLDN)
Mary K. Wojczynski et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2015)
A novel risk score to predict cardiovascular disease risk in national populations (Globorisk): a pooled analysis of prospective cohorts and health examination surveys
Kaveh Hajifathalian et al.
LANCET DIABETES & ENDOCRINOLOGY (2015)
OptimalCutpoints: AnRPackage for Selecting Optimal Cutpoints in Diagnostic Tests
Mónica López-Ratón et al.
Journal of Statistical Software (2015)
Postprandial hypertriglyceridemia as a coronary risk factor
Jan Boren et al.
CLINICA CHIMICA ACTA (2014)
Postprandial lipemia as a cardiometabolic risk factor
Angela Pirillo et al.
CURRENT MEDICAL RESEARCH AND OPINION (2014)
Postprandial lipemia and cardiovascular disease risk: Interrelationships between dietary, physiological and genetic determinants
Kim G. Jackson et al.
ATHEROSCLEROSIS (2012)
pROC: an open-source package for R and S plus to analyze and compare ROC curves
Xavier Robin et al.
BMC BIOINFORMATICS (2011)
Triglycerides and Cardiovascular Disease A Scientific Statement From the American Heart Association
Michael Miller et al.
CIRCULATION (2011)
Nutrigenetics of the Postprandial Lipoprotein Metabolism: Evidences From Human Intervention Studies
Pablo Perez-Martinez et al.
CURRENT VASCULAR PHARMACOLOGY (2011)
Assessment and Clinical Relevance of Non-Fasting and Postprandial Triglycerides: An Expert Panel Statement
Genovefa D. Kolovou et al.
Current Vascular Pharmacology (2011)
Nonfasting triglycerides and risk of cardiovascular death in men and women from the Norwegian Counties Study
Anja S. Lindman et al.
EUROPEAN JOURNAL OF EPIDEMIOLOGY (2010)
Apolipoprotein B and Cardiovascular Disease Risk: Position Statement from the AACC Lipoproteins and Vascular Diseases Division Working Group on Best Practices
John H. Contois et al.
CLINICAL CHEMISTRY (2009)
Oral fat load effects on inflammation and endothelial stress markers in healthy subjects
Giuseppe Derosa et al.
HEART AND VESSELS (2009)
Fasting compared with nonfasting triglycerides and risk of cardiovascular events in women
Sandeep Bansal et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Nonfasting triglycerides and risk of myocardial infarction, ischemic heart disease, and death in men and women
Borge G. Nordestgaard et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Postprandial inflammation and endothelial dysfuction
A. Alipour et al.
BIOCHEMICAL SOCIETY TRANSACTIONS (2007)
Apolipoprotein B and A-I distribution in Mexican urban adults:: Results of a nationwide survey
V Valles et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2002)
Postprandial endothelial activation in healthy subjects and in type 2 diabetic patients: Role of fat and carbohydrate meals
F Nappo et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2002)